Key facts
- This page summarizes Peter James McGregor's Form 3 filing for Imricor Medical Systems, Inc..
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 18 May 2026, 17:06.
Peter James McGregor - 18 May 2026 Form 3 Insider Report for Imricor Medical Systems, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 18 May 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Peter James McGregor
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Peter James McGregor filed Form 3 for Imricor Medical Systems, Inc. on 18 May 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002134603
Primary reporting owner
McGregor Peter James
- Relationship
- Director
- Address
- C/O IMRICOR MEDICAL SYSTEMS, INC., 400 GATEWAY BLVD, BURNSVILLE
- Signature
- /s/ Peter James McGregor
- Signature date
- 18 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 502,452
- Date
- 18 May 2026
- Ownership
- Direct
- Footnotes
- F1, F2
No ticker
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 380,000
- Date
- 18 May 2026
- Ownership
- By family trust
- Footnotes
- F1, F3
No ticker
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 60,000
- Date
- 18 May 2026
- Ownership
- By estate trust
- Footnotes
- F1, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 135,000
- Exercise price
- $0.9800
- Footnotes
- F5
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 71,010
- Exercise price
- $0.8900
- Footnotes
- F6
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 40,896
- Exercise price
- $1.57
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The amounts reported in column 2 include shares of the issuer's Class A Common Stock underlying the same number of CHESS Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty Limited, a subsidiary of ASX Limited, the company that operates the ASX.
Footnote F2
The amount of securities beneficially owned in column 2 includes 157,998 restricted stock awards ("RSAs") granted under the issuer's 2019 Equity Incentive Plan. Each RSA represents one CDI, which represents one share of the issuer's Class A Common Stock, subject to vesting conditions. The reporting person holds: (i) 44,943 RSAs remaining unvested from a May 12, 2023 grant, which RSAs will vest on May 12, 2027; (ii) 53,778 RSAs remaining unvested from a May 15, 2024 grant, which RSAs will vest 50% on each of May 15, 2027 and May 15, 2028; (iii) 30,960 RSAs remaining unvested from a May 14, 2025 grant, which RSAs will vest one-third on each of May 14, 2027, May 14, 2028, and May 14, 2029; and (iv) 28,317 RSAs granted on May 8, 2026, which RSAs will vest 25% on each of May 8, 2027, May 8, 2028, May 8, 2029, and May 8, 2030, subject in each case to the reporting person's continued service through each such vesting date.
Footnote F3
Represents shares held by the P & B McGregor family trust, for which Mrs. Bernadette Mary McGregor and the reporting person are account holders. The reporting person may be deemed to beneficially own the shares held by the trust. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Footnote F4
Represents shares held in the account of Mrs. Eva Joy McGregor for the Estate of Graeme McGregor. The reporting person serves as trustee and makes all investment decisions for the trust. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Footnote F5
This option was granted on August 30, 2019, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.
Footnote F6
This option was granted on May 13, 2020, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.
Footnote F7
This option was granted on May 7, 2021, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.